More articles from Mesothelioma

Exhaled breath to screen for malignant pleural mesothelioma: a validation study
Kevin Lamote, Matthijs Vynck, Olivier Thas, Joris Van Cleemput, Kristiaan Nackaerts, Jan P. van Meerbeeck

European Respiratory Journal Dec 2017, 50 (6) 1700919; DOI: 10.1183/13993003.00919-2017
Impact of tumour thickness on survival after radical radiation and surgery in malignant pleural mesothelioma
Marc de Perrot, Zhi Dong, Penelope Bradbury, Demetris Patsios, Shaf Keshavjee, Natasha B. Leighl, Andrew Hope, Ronald Feld, John Cho

European Respiratory Journal Mar 2017, 49 (3) 1601428; DOI: 10.1183/13993003.01428-2016
Incidence and familial risk of pleural mesothelioma in Sweden: a national cohort study
Jianguang Ji, Jan Sundquist, Kristina Sundquist

European Respiratory Journal Sep 2016, 48 (3) 873-879; DOI: 10.1183/13993003.00091-2016
Mesothelioma incidence projections in South East England
Sharma P. Riaz, Victoria H. Coupland, Margreet Lüchtenborg, Michael D. Peake, Henrik Møller

European Respiratory Journal Oct 2012, 40 (4) 965-968; DOI: 10.1183/09031936.00168111
A breath test for malignant mesothelioma using an electronic nose
Eleanor A. Chapman, Paul S. Thomas, Emily Stone, Craig Lewis, Deborah H. Yates

European Respiratory Journal Aug 2012, 40 (2) 448-454; DOI: 10.1183/09031936.00040911
A 5-aza-2′-deoxycytidine/valproate combination induces cytotoxic T-cell response against mesothelioma
S. Leclercq, F. Gueugnon, B. Boutin, F. Guillot, C. Blanquart, A. Rogel, M. Padieu, D. Pouliquen, J-F. Fonteneau, M. Grégoire

European Respiratory Journal Nov 2011, 38 (5) 1105-1116; DOI: 10.1183/09031936.00081310
Recognition of pleural mesothelioma by mucin-1(950–958)/human leukocyte antigen A*0201-specific CD8+ T-cells
D. Roulois, V. Vignard, F. Gueugnon, N. Labarrière, M. Grégoire, J-F. Fonteneau

European Respiratory Journal Nov 2011, 38 (5) 1117-1126; DOI: 10.1183/09031936.00160210

Main menu

User menu

Search

More articles from Mesothelioma

Contact us